Effects of cratagus herbal consumption and erobic exercise in patients with stable angina pectoris

Effects of Crataegus herbal consumption or aerobic excercise on risk factors of cardiovascular diseases in patients with stable angina pectoris

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013021812521N1

Enrollment

Registered

2013-04-21

Start date

2013-05-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stable angina pectoris. Angina pectoris, unspecified

Interventions

Intervention 1: Crataegus herbal, 240 mg pill, two times a day for three months. Intervention 2: Aerobic exercise, 15 to 20 minutes, two times a day for three months. Intervention 3: Placebo, 240 Mg p

Treatment - Drugs

Rehabilitation

Placebo

Crataegus herbal, 240 mg pill, two times a day for three months.

Aerobic exercise, 15 to 20 minutes, two times a day for three months.

Placebo, 240 Mg pill, two times a day with aerobic exercise, 15 to 20 minutes, two times a day for three months.

Control group with no intervention for three months.

Eligibility

Sex/Gender

All

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: In this study, petients who had been undergone coronary angiography testing . They are approved, but there was no significant stenosis. In addition, patients with heart failure treated with digoxin, anticoagulant , anti-arrhythmic drugs and cisapride are excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
CRP. Timepoint: Before The intervention, and three months after intervention. Method of measurement: Mg per deciliter.;IL-6. Timepoint: Before The intervention, and three months after intervention. Method of measurement: Mg per deciliter.	—

Secondary

Measure	Time frame
Resting heart rate. Timepoint: Before interfered. Method of measurement: bpm.;Heart rate reserve. Timepoint: Before interfered. Method of measurement: bpm.;Maximum heart rate. Timepoint: Before interfered. Method of measurement: bpm.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Rafieian Mahmoud

Shahrekord University of Medical Sciences

rafieian@skums.ac.ir+98 213813346692

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026